BioNTech SE (NASDAQ:BNTX)

195.90
Delayed Data
As of Jan 14
 -7.09 / -3.49%
Today’s Change
90.29
Today|||52-Week Range
464.00
-24.01%
Year-to-Date
3 Top Dividend Stocks to Buy Now
Jan 16 / MotleyFool.com - Paid Partner Content
Moderna Plans March Release of Children's Vaccine Trial Data
Jan 13 / GuruFocus News - Paid Partner Content
Is the COVID-19 Investing Boom Over?
Jan 15 / MotleyFool.com - Paid Partner Content
Vaxxinity (VAXX) Starts Dosing in Parkinson's Disease Study
Jan 13 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) COVID-19 Booster Dose Useful Against Omicron
Jan 14 / Zacks.com - Paid Partner Content
Ocugen's (OCGN) COVID-19 Booster Effective Against Omicron
Jan 13 / Zacks.com - Paid Partner Content
Why Pfizer and BioNTech Got Thrashed on Thursday
Jan 13 / MotleyFool.com - Paid Partner Content
Pfizer's (PFE) Prevnar 20 Plus COVID Vaccine Study Succeeds
Jan 13 / Zacks.com - Paid Partner Content
Why Shares of BioNTech Rose 216% in 2021
Jan 13 / MotleyFool.com - Paid Partner Content
5 Reasons Why Pfizer Is a Better Stock to Buy Right Now Than Moderna
Jan 13 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close202.99
Today’s open194.52
Day’s range194.52 - 205.93
Volume104,136
Average volume (3 months)3,241,583
Market cap$47.5B
Data as of 4:00pm ET, 01/14/2022

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+60,843.11%
Earnings growth (next 5 years)+578.31%
Revenue growth (last year)+352.40%
P/E ratio5.6
Price/Sales36.85
Price/Book28.18

Competitors

No competitors data available.

Financials

Next reporting dateApril 5, 2022
EPS forecast (this quarter)$7.67
Annual revenue (last year)$549.8M
Annual profit (last year)$17.3M
Net profit margin3.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts